Zoledronic Acid Sensitizes Renal Cell Carcinoma Cells to Radiation by Downregulating STAT1

Zoledronic acid (ZOL), a third-generation bisphosphonate that strongly inhibits osteoclast activity, is widely used for the treatment of bone metastasis from a variety of malignancies, including renal cell carcinoma (RCC). We previously reported that zoledronic acid (ZOL) clinically potentiates anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kijima, Toshiki, Koga, Fumitaka, Fujii, Yasuhisa, Yoshida, Soichiro, Tatokoro, Manabu, Kihara, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669422/
https://www.ncbi.nlm.nih.gov/pubmed/23741352
http://dx.doi.org/10.1371/journal.pone.0064615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669422/
https://www.ncbi.nlm.nih.gov/pubmed/23741352
http://dx.doi.org/10.1371/journal.pone.0064615

Ejemplares similares